Fintel reports that on July 7, 2025, JP Morgan upgraded their outlook for Phibro Animal Health (NasdaqGM:PAHC) from Neutral to Overweight. Analyst Price Forecast Suggests 28.96% Downside As of June 20 ...
Original Image Link
Source:www.msn.com
Original Image Link
Source:www.msn.com
Posted: 2025-07-07 05:39:31